210 related articles for article (PubMed ID: 8923839)
1. Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values.
Brossard JH; Cloutier M; Roy L; Lepage R; Gascon-Barré M; D'Amour P
J Clin Endocrinol Metab; 1996 Nov; 81(11):3923-9. PubMed ID: 8923839
[TBL] [Abstract][Full Text] [Related]
2. The set point of parathyroid hormone stimulation by calcium is normal in progressive renal failure.
Cardinal H; Brossard JH; Roy L; Lepage R; Rousseau L; D'Amour P
J Clin Endocrinol Metab; 1998 Nov; 83(11):3839-44. PubMed ID: 9814455
[TBL] [Abstract][Full Text] [Related]
3. Intravenous 1,25(OH)2D therapy increases the intact parathyroid hormone secretion set point in hemodialyzed patients.
Brossard JH; Roy L; Lepage R; Gascon-Barré M; D'Amour P
Miner Electrolyte Metab; 1997; 23(1):25-32. PubMed ID: 9058366
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunoassay of carboxyl and amino terminal fragments of parathyroid hormone for the evaluation of secondary hyperparathyroidism in chronic renal failure.
Zanella MT; Silva MC; Peres RB; Ferreira SR; Draibe SA; Vieira JG
Braz J Med Biol Res; 1990; 23(3-4):235-43. PubMed ID: 2094538
[TBL] [Abstract][Full Text] [Related]
5. The modulation of circulating parathyroid hormone immunoheterogeneity in man by ionized calcium concentration.
D'Amour P; Palardy J; Bahsali G; Mallette LE; DeLéan A; Lepage R
J Clin Endocrinol Metab; 1992 Mar; 74(3):525-32. PubMed ID: 1740486
[TBL] [Abstract][Full Text] [Related]
6. Influence of Ca2+ concentration on the clearance and circulating levels of intact and carboxy-terminal iPTH in pentobarbital-anesthetized dogs.
D'Amour P; Rousseau L; Rocheleau B; Pomier-Layrargues G; Huet PM
J Bone Miner Res; 1996 Aug; 11(8):1075-85. PubMed ID: 8854243
[TBL] [Abstract][Full Text] [Related]
7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
8. Origin of parathyroid hormone (PTH) fragments detected by intact-PTH assays.
Nguyen-Yamamoto L; Rousseau L; Brossard JH; Lepage R; Gao P; Cantor T; D'Amour P
Eur J Endocrinol; 2002 Jul; 147(1):123-31. PubMed ID: 12088929
[TBL] [Abstract][Full Text] [Related]
9. Calcium metabolism in early chronic renal failure: implications for the pathogenesis of hyperparathyroidism.
Reichel H; Deibert B; Schmidt-Gayk H; Ritz E
Nephrol Dial Transplant; 1991; 6(3):162-9. PubMed ID: 1866044
[TBL] [Abstract][Full Text] [Related]
10. Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery.
Räkel A; Brossard JH; Patenaude JV; Albert C; Nassif E; Cantor T; Rousseau L; D'Amour P
Clin Endocrinol (Oxf); 2005 Jun; 62(6):721-7. PubMed ID: 15943835
[TBL] [Abstract][Full Text] [Related]
11. Circulating intact parathyroid hormone measured by a two-site immunochemiluminometric assay.
Brown RC; Aston JP; Weeks I; Woodhead JS
J Clin Endocrinol Metab; 1987 Sep; 65(3):407-14. PubMed ID: 3624408
[TBL] [Abstract][Full Text] [Related]
12. Abnormalities of parathyroid hormone secretion in elderly women that are reversible by short term therapy with 1,25-dihydroxyvitamin D3.
Ledger GA; Burritt MF; Kao PC; O'Fallon WM; Riggs BL; Khosla S
J Clin Endocrinol Metab; 1994 Jul; 79(1):211-6. PubMed ID: 8027229
[TBL] [Abstract][Full Text] [Related]
13. Relationship of predialytic intact parathyroid hormone on secondary hyperparathyroidism in chronic maintenance haemodialysis patients.
Etoh S; Murata T; Hasegawa Y; Miyahara Y; Ishimura A; Abe Y; Noda R; Ogahara S; Kaneoka H; Saito T
Nephrology (Carlton); 2004 Jun; 9(3):161-6. PubMed ID: 15189177
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the calcium-PTH axis and renal handling of phosphate by calcium and citrate clamp techniques in normal subjects and in patients with heavy proteinuria.
Saha H; Seppälä E; Mörsky P; Mustonen J; Pasternack A
Clin Nephrol; 1997 Dec; 48(6):364-70. PubMed ID: 9438095
[TBL] [Abstract][Full Text] [Related]
15. Frusemide therapy and intact parathyroid hormone plasma concentrations in chronic renal insufficiency.
Reichel H; Deibert B; Geberth S; Schmidt-Gayk H; Ritz E
Nephrol Dial Transplant; 1992; 7(1):8-15. PubMed ID: 1316586
[TBL] [Abstract][Full Text] [Related]
16. Hyperparathyroidism, platelet intracellular free calcium and hypertension in chronic renal failure.
Raine AE; Bedford L; Simpson AW; Ashley CC; Brown R; Woodhead JS; Ledingham JG
Kidney Int; 1993 Mar; 43(3):700-5. PubMed ID: 8455369
[TBL] [Abstract][Full Text] [Related]
17. The calcitonin-calcium relation curve and calcitonin secretory parameters in renal patients with variable degrees of renal function.
Messa P; Mioni G; Turrin D; Guerra UP
Nephrol Dial Transplant; 1995 Dec; 10(12):2259-65. PubMed ID: 8808222
[TBL] [Abstract][Full Text] [Related]
18. Amino-terminal form of parathyroid hormone (PTH) with immunologic similarities to hPTH(1-84) is overproduced in primary and secondary hyperparathyroidism.
D'Amour P; Brossard JH; Rousseau L; Roy L; Gao P; Cantor T
Clin Chem; 2003 Dec; 49(12):2037-44. PubMed ID: 14633875
[TBL] [Abstract][Full Text] [Related]
19. Evolution of the parathyroid hormone (PTH) assay--importance of circulating PTH immunoheterogeneity and of its regulation.
Gao P; D'Amour P
Clin Lab; 2005; 51(1-2):21-9. PubMed ID: 15719701
[TBL] [Abstract][Full Text] [Related]
20. A novel mechanism for skeletal resistance in uremia.
Slatopolsky E; Finch J; Clay P; Martin D; Sicard G; Singer G; Gao P; Cantor T; Dusso A
Kidney Int; 2000 Aug; 58(2):753-61. PubMed ID: 10916099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
